Encompass Health Corporation (EHC) Institutional Ownership & Insider Trading

595 institutions reported holding Encompass Health Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 18 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EHCEncompass Health CorporationFollow EHC — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 12.2B
P/E TTM: 20.2
Dividend yield: 0.6%
52-week: —
Next earnings: 28 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

595 institutions held 96.6% of the shares. Across filers that reported both quarters, shares held changed -1.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	595	95	-1.9%	194	46	191	29
Mar 26	574	96	-4.2%	211	57	172	69
Dec 25	581	101	+4.9%	155	50	231	69
Sep 25	594	95	+1.5%	200	39	193	35
Jun 25	598	95	-1.6%	175	98	201	26
Mar 25	528	95	+0.5%	174	44	170	47
Dec 24	536	95	-2.6%	176	61	133	23
Sep 24	474	94	-1.1%	139	35	171	32

Encompass Health Corporation — questions

Who owns Encompass Health Corporation stock?: 595 institutions reported Encompass Health Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.6%), PRICE T ROWE ASSOCIATES INC /MD/ (5.1%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.0%).
Are Encompass Health Corporation insiders buying or selling?: 18 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Encompass Health Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.